Dr. Redfield, who became the C.D.C. Redfield has expressed to Secretary Azar that he does not wish to have his compensation become a distraction for the important work of the C.D.C.,” an H.H.S. secretary; Dr. Scott Gottlieb, head of the Food and Drug Administration; and Dr. Francis Collins, director of the National Institutes of Health. The selection of Dr. Redfield was the right choice at the right time for the right purpose. She asked whether the agency made an “extensive and exhaustive” effort to find a director before deciding to pay Dr. Redfield under the special exemption.

Source: New York Times April 30, 2018 18:45 UTC